
CMS and AHIP Isn’t the Finish Line: It’s the Starting Gun for Prior Auth Innovation
Without systemic redesign, these efforts risk reinforcing the same pain points that made prior authorization a flashpoint for payers and providers.
Without systemic redesign, these efforts risk reinforcing the same pain points that made prior authorization a flashpoint for payers and providers.
Inaccuracies don’t just erode trust — they lead directly to surprise billing events, missed appointments, care delays, and in some cases, enforcement action.
At a time when AI is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an interview why empathy, context, and ethics still require a human touch.
Although the healthcare industry has a long way to go before PGx testing for DPYD and other genes becomes widespread, it's encouraging that regulatory bodies and professional organizations are making recommendations and raising awareness among healthcare providers.
From the operating room to the front desk, robotics are now being integrated into a variety of applications with the purpose of freeing up time and services for healthcare workers to do what they do best, patient care.
The conversations in Nashville reinforced the idea that while innovation remains essential, vendors must navigate the fine balance between bold ideas and real-world implementation, demonstrating not just promise but tangible outcomes.
While new technologies may demonstrate clinical benefits in controlled settings, their true value is determined by how well they fit into existing healthcare workflows.
Break down the silos. Take control of your provider data.
The transition to hybrid measures in 2024 has been more than just a regulatory requirement — it's been a catalyst for meaningful change in how we approach quality reporting. Here are five critical insights that can help healthcare organizations comply with requirements and excel in their quality reporting journey.
AI/big data haven't solved healthcare's challenges. Despite advancements, systemic barriers persist, but AI offers potential to improve outcomes and efficiency.
Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things to look for include more widespread adoption of artificial intelligence technologies and the IPO market’s return to normal levels.
Trends in ICHRA adoption, product innovation, and regulatory developments signal that this benefits model isn’t just here to stay — it’s poised to help redefine how we think about employer-sponsored healthcare.
A new report by Paubox calls for healthcare IT leaders to dispose of outdated assumptions about email security and address the challenges of evolving cybersecurity threats.
The impact of private equity investments in healthcare under the new administration is multifaceted. While deregulation and business-friendly policies could stimulate investment and drive innovation, there are significant concerns about the potential negative effects on healthcare quality and access.
This week at HLTH, FDA Commissioner Robert Califf discussed the current state of healthcare AI. He talked about some of the qualms he has, such as his worry that AI is worsening health inequities and his concern that providers aren’t capable of validating AI tools’ effectiveness.
Many great ideas fail because of a fundamental misunderstanding or underestimation of the unique barriers entrenched within healthcare. Here are some key considerations that innovators from non-healthcare backgrounds need to be prepared for.
In healthcare, a faulty algorithm can be a matter of life and death.
America should be a global leader in healthcare. Instead, we rank last among our peers, and outmoded regulations are holding us back.